Marina Mauro

Marina Mauro

Director, Patents

Marina Mauro’s core area of expertise lies within the field of organic chemistry. She has a focus on pharmaceutical drugs and imaging agents for diagnostic medicine such as x-ray imaging, magnetic resonance imaging, contrast enhanced ultrasound and nuclear medicine through radioactive tracers.

Marina has significant experience in developing and managing worldwide patent portfolios — including the preparation and prosecution of patent applications — around new therapeutic and diagnostic products. She also advises on both patentability (opinion) and freedom to operate (FTO), in addition to Supplementary Patent Certificates (SPCs) in her role as a technical expert in patent and SPC litigations (to which she was appointed by Italian Judges). Marina is also a qualified European Litigator, able to represent clients in front of the European Unified Court.

Having held in-house managerial positions at multinational pharmaceutical companies including GlaxoSmithKline and Bracco Group, Marina has a deep understanding of clients’ strategic IP needs. She is equally adept when working with small- and medium-sized companies and research centres to develop their IP estates and derive maximum return from IP spend.

Marina’s scientific credentials include a Doctorate in Chemistry from the University of Milan and three years working as a senior scientist at the Sigma-Tau Prassis Institute, where she researched new antihypertensive drugs. She has authored many scientific publications and is a named patent inventor.

In 2022, Marina was elected as a Member of the Disciplinary Board of the Italian Industrial Property Consultants Institute. She is actively involved in lecturing on IP-related issues and tutoring for the Italian Qualifying Examination.

A key part of our Patent Box team, Marina advises many clients with business interests in Italy on how maximise the benefit they receive from the scheme. Marina is also part of our dedicated unitary patent team which advises on all aspects of the Unified Patent Court.

Marina joined Murgitroyd in 2011. She was appointed Director, Patents in August 2021.

  • Chemie
  • Organische Chemie
  • Materials
  • Life Sciences
  • Healthcare
  • Pharmaceuticals
  • Pharmaceuticals drugs
  • Diagnostic medicine
  • X-ray imaging
  • Magnetic resonance imaging
  • Ultrasounds
  • Nuclear medicine
  • Radioactive tracers
  • Diagnostic products
  • Antihypertensive drugs

Key contributor to our Chemistry & Materials Team awarded Gold by the Financial Times.

Financial Times European Leading Patent Law Firms, combined - 2019, 2020, 2022, 2023 and 2024

Utilising her expertise, Marina devises protective strategies, manages and optimises the monetary value of global patent portfolios on behalf start-ups, SMEs and research centres. Her knowledge is also called on for patentability advice, freedom-to-operate searches and SPCs.

IAM 1000 - 2024

On the organic chemistry side, Marina Mauro is active in the pharmaceutical drugs and imaging agents for diagnostic medicine sphere, with in-house experience in managerial positions at leading pharmaceutical conglomerates.

IAM 1000 - 2024

Key contributor to our Life Sciences & Healthcare Team awarded Gold by the Financial Times

Financial Times European Leading Patent Law Firms, combined Pharmaceuticals, Biotechnology, Food & Healthcare awards - 2019, 2022 and 2023

Member of the China Team awarded "Most Recommended International IP Agencies" 2024

China in-house IP Managers Annual Conference - 2024

Congratulation to the team for successfully defending our patent in oral hearing today. It is good we don’t need to amend the claim!

Senior Research Scientist, US Chemical Company

Recommended in Italy by IAM 1000

IAM 1000 - 2023

FT LOGO RGB COL WEB
IP STARS LOGO RGB COL WEB
THE LEGAL 500 LOGOTYPE RGB
IAM300 LOGO RGB COL WEB
IAM1000 LOGO RGB COL WEB
WTR LOGO RGB COL
WWL LOGO RGB COL WEB
Logo 2024 Most Recommended Intl IP Agencies Service 1
Decideurs Magazine Full RGB
WIPR 2024 Diversity Woman Logo Colour RGB
Social Impact Awards 2024 final
IP INCLUSIVE WEB
Adapt Legal Logo RGB
EPPP Logo web size
Lsa logo 2024 CMYK
Cyber Essentials certified final
Cyber Essentials PLUS final
BVCA logo Colour